Qilian international holding group limited

Other-Pharmaceuticals

QLI


Executive/
Director

Price

  • Last Close
  • $ 0.85
    $ +0.07 9.11 %
    Jun 20, 2024
  • 52-Week High/Low
  • $1.04 - $0.39
  • YTD
  • 16%

  • Trading Volume
  • 7,327
  • Market Cap Full
  • $ 30.4M
  • Shares Outstanding
  • 35.8M
    Sep 30, 2022
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - - - -35.9% 79.2% -13.4%
Q2 - - - - - - -9.9% 16.5% -33.3% -12.1%
Q3 - - - - - - -4% -39.9% -2.3% -
Q4 - - - - - - -34.4% -39.5% -6.9% -
J F M A M J J A S O N D
2024 -25.2% -26.8% 58.4% -8.7% - - - - - - - -
2023 141.7% -23% -3.7% -2.3% -23.8% -10.4% -4.8% -2.8% 5.5% -50% 8.8% 60.4%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%0%-73%2%16%

Earnings

2019 2020 2021 2022 2023
Q1 - - - - -
Q2 - - - - -
Q3 - - - - -
Q4 - - - - -
A 0.2 0.2 0.1 0 0

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022
Mar - - -
Jun - - -
Sep 30 35.8 35.8
Dec - - -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 6.6 3.9 3.5 2.8 4.4
Fixed Asset Turnover 2 1.8 6.3 5.1 4.5
Total Asset Turnover 1 0.8 1 1.3 1.5
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 2 -2 - 6 7.5
Equity multiplier 0.6 0.6 0.3 0.4 0.6